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Abstract
The aim of this study was to explore the molecular profile of proliferating rheumatoid arthritis synovial
fibroblasts (RA-SF). Total RNA was extracted from two cultures of RA-SF (low-density [LD]
proliferating cells and high-density [HD] nonproliferating cells) and suppression subtractive
hybridization was performed to compare differential gene expression of these two cultures. Subtracted
cDNA was subcloned, and nucleotide sequences were analyzed to identify each clone. Differential
expression of distinct clones was confirmed by semiquantitative RT-PCR. The expression of certain
genes in synovial tissues was examined by in situ hybridization. In both LD and HD cells, 44 clones
were upregulated. Of the 88 total clones, 46 were identical to sequences that have previously been
characterized. Twenty-nine clones were identical to cDNAs that have been identified, but with unknown
functions so far, and 13 clones did not show any significant homology to sequences in GenBank
(NCBI). Differential expression of distinct clones was confirmed by RT-PCR. In situ hybridization
showed that certain genes, such as S100A4, NFAT5, unr and Fbx3, were also expressed predominantly
in synovial tissues from patients with RA but not from normal individuals. The expression of distinct
genes in proliferating RA-SF could also be found in RA synovium, suggesting that these molecules are
involved in synovial activation in RA. Most importantly, the data indicate that the expression of certain
genes in RA-SF depends on the stage of proliferation; therefore, the stage needs to be considered in any
analysis of differential gene expression in SF.
Introduction
Recently, several lines of evidence indicated that the
balance between apoptotic cell death and proliferation or
differentiation appears to be modulated in the rheumatoid
arthritis (RA) synovium [1–3]. In our laboratory, it was
demonstrated that sentrin-1, which is identical to small
ubiquitin-related modifier (SUMO)-1, is upregulated in cul-
tured RA synovial fibroblasts (SF) as well as at sites of
invasion [4]. Sentrin-1 is thought to modify the activity of
Mdm2, which is also expressed in RA-SF [5]. Mdm2 is an
E3 ubiquitin ligase for p53, and degrades p53 protein in a
proteasome-dependent manner [6], suggesting that
sentrin-1 is able to modulate the apoptotic pathway in RA
synovial tissues. Moreover, we also reported that FLICE
(Fas-associating protein with death domain [FADD]-like
interleukin 1β converting enzyme [ICE]) inhibitory protein
13kdap = 13kDa differentiation-associated protein; Apaf-1 = apoptotic protease-activating factor-1; AZI = antizyme inhibitor; BCIP = 5-bromo-4-
chloro-3-indolyl-phosphate, 4-toluidine salt; ECM = extracellular matrix; EFEMP1 = EGF-containing fibulin-like extracellular matrix protein 1; EPLIN =
epithelial protein lost in neoplasm; Fbx3 = F-box only protein 3; FLICE = Fas-associating protein with death domain [FADD]-like interleukin 1β con-
verting enzyme [ICE]; FLIP = FLICE inhibitory protein; HD = high-density; HE = hematoxylin and eosin; LD = low-density; NAP1L1 = nucleosome
assembly protein 1-like 1; NBT = 4-nitro blue tetrazolium chloride; NCBI = National Center for Biotechnology Information; NFAT5 = nuclear factor
of activated T cells 5; PCNA = proliferating cell nuclear antigen; PDGF = platelet-derived growth factor; RA = rheumatoid arthritis; RNASE4 =
ribonuclease 4; RT-PCR = reverse transcriptase-polymerase chain reaction; S100A4 = S100 calcium-binding protein A4; SF = synovial fibroblasts;
SUMO = small ubiquitin-related modifier; unr = upstream of N-ras.
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Abstract
The aim of this study was to explore the molecular profile of
proliferating rheumatoid arthritis synovial fibroblasts (RA-SF).
Total RNA was extracted from two cultures of RA-SF (low-
density [LD] proliferating cells and high-density [HD]
nonproliferating cells) and suppression subtractive
hybridization was performed to compare differential gene
expression of these two cultures. Subtracted cDNA was
subcloned, and nucleotide sequences were analyzed to identify
each clone. Differential expression of distinct clones was
confirmed by semiquantitative RT-PCR. The expression of
certain genes in synovial tissues was examined by in situ
hybridization. In both LD and HD cells, 44 clones were
upregulated. Of the 88 total clones, 46 were identical to
sequences that have previously been characterized. Twenty-
nine clones were identical to cDNAs that have been identified,
but with unknown functions so far, and 13 clones did not show
any significant homology to sequences in GenBank (NCBI).
Differential expression of distinct clones was confirmed by RT-
PCR. In situ hybridization showed that certain genes, such as
S100A4, NFAT5, unr and Fbx3, were also expressed
predominantly in synovial tissues from patients with RA but not
from normal individuals. The expression of distinct genes in
proliferating RA-SF could also be found in RA synovium,
suggesting that these molecules are involved in synovial
activation in RA. Most importantly, the data indicate that the
expression of certain genes in RA-SF depends on the stage of
proliferation; therefore, the stage needs to be considered in
any analysis of differential gene expression in SF. 
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(FLIP), an inhibitor of caspase 8, is expressed predomi-
nantly at sites of bone and cartilage destruction in RA [7].
These results indicate that several anti-apoptotic mecha-
nisms most likely play a critical role in maintaining the
long-term activation of RA-SF and thereby contribute to
matrix degradation.
In addition to the expression of these anti-apoptotic mole-
cules, RA-SF show several features with regard to cell
proliferation. Lafyatis et al. [8] reported that RA-SF reveal
anchorage-independent cell growth under certain culture
conditions, such as high serum concentration (20%) or
platelet-derived growth factor (PDGF) supplementation.
Moreover, it has been shown that PDGF and PDGF
receptor [9], c-myc [10,11] and proliferating cell nuclear
antigen (PCNA) [10], which are cell proliferation-associ-
ated molecules, are predominantly expressed in rheuma-
toid synovium.
On the basis of these observations, we hypothesized that
proliferating RA-SF express a specific set of genes that pro-
motes proliferation and/or inhibits the apoptotic process.
Thus, the aim of this study was to investigate the expression
profile of RA-SF during proliferation in comparison with that
of nonproliferating RA-SF, and thereby to explore novel mol-
ecular mechanisms of synovial proliferation in RA.
Materials and methods
Preparation of synovial fibroblasts
Cultured RA-SF from one patient (SHK70) who fulfilled
the 1987 revised criteria of the American College of
Rheumatology for the disease were propagated from syn-
ovial tissue obtained during synovectomy, and were used
for cDNA subtraction. Briefly, the tissue specimens were
minced enzymatically, and the adherent cells were cul-
tured in Dulbecco’s modified Eagle’s medium (Life Tech-
nologies AG, Basel, Switzerland) supplemented with 10%
fetal calf serum. The cells were cultured until reaching
confluence, then trypsinized and spread to new culture
flasks in a 1:5 dilution. The cells were cultured for the sixth
passage, and the cells in passage six were used for sup-
pression subtractive hybridization. Two other RA-SF from
different patients with RA (SHK78 and SHK80) were also
used for RT-PCR.
RNA isolation and suppression subtractive hybridization
Total RNA was extracted with TRIZOL® reagent (Life
Technologies AG, Basel, Switzerland) from two cultures, 4
days after seeding (LD; low-density cells) and 14 days
after seeding (HD; high-density cells), respectively (see
Supplementary material). From each culture, 1 µg of total
RNA was used for cDNA synthesis with the SMART™
PCR cDNA Synthesis Kit (BD Clontech, Basel, Switzer-
land), and suppression subtractive hybridization was per-
formed with the PCR-Select™ cDNA Subtraction Kit (BD
Clontech, Basel, Switzerland) according to the manufac-
turer’s instructions. We performed two directional subtrac-
tions. In the forward (LD-specific) subtraction, we investi-
gated the genes specifically expressed on day 4 in
proliferating cells at low density. We also conducted
reverse (HD-specific) subtraction to analyze the genes
predominantly expressed on day 14 in nonproliferating
cells at high density. Each subtracted cDNA was sub-
cloned into PCR-Script Amp SK (+) cloning vector (Strat-
agene Europe, Amsterdam, The Netherlands). After
plasmid DNA of each clone was purified using Concert™
Rapid Plasmid Purification Systems (Life Technologies
AG, Basel, Switzerland), the nucleotide sequences were
analyzed by commercial sequencing (Microsynth, Balgach,
Switzerland), and BLAST searches (NCBI) were per-
formed to identify the respective gene of each clone.
Semiquantitative RT-PCR
We designed primers specific for distinct genes, i.e.
antizyme inhibitor (AZI), EGF-containing fibulin-like extra-
cellular matrix protein 1 (EFEMP1), S100 calcium-binding
protein A4 (S100A4), nuclear factor of activated T cells 5
(NFAT5), upstream of N-ras (unr), F-box only protein 3
(Fbx3), ribonuclease 4 (RNASE4), dipeptidylpeptidase IV
(CD26), epithelial protein lost in neoplasm (EPLIN) and
13 kDa differentiation-associated protein (13kdap). Then,
mRNA expression was analyzed by semiquantitative
RT-PCR to confirm the differential expression of the sub-
tracted cDNA. At first, template cDNA was diluted 1: 3
and 1: 9, and PCR with primers of housekeeping genes
such as actin β and glyceraldehyde-3-phosphate dehydro-
genase (GAPDH) was performed to compare the equal
amounts of cDNA between two cultures in further experi-
ments. Then, the efficiency of the amplification and the
optimal cycles were confirmed for each set of primers.
After this optimization, we compared the expression of
each gene. All PCR reactions consisted of initial denatura-
tion at 94°C for 10 min followed by 25 to 35 cycles at
94°C for 30 s, 58 to 60°C for 1 min, and 72°C for 90 s
performed by using AmpliTaq Gold® DNA polymerase and
GeneAmp PCR system 9700 (Applied Biosystems,
Rotkreuz, Switzerland). PCR products were analyzed on
1.0% agarose gels.
In situ hybridization
The expression and distribution of distinct genes were
examined in paraffin-embedded sections of synovial
tissues from seven patients with RA and three normal indi-
viduals by in situ hybridization with digoxigenin-labeled
RNA probes, which were generated by in vitro transcrip-
tion with T3 or T7 RNA polymerases. The probes were
detected with alkaline-phosphatase-conjugated anti-digox-
igenin antibody F (ab), and visualized with 4-nitro blue
tetrazolium chloride (NBT) and 5-bromo-4-chloro-3-
indolyl-phosphate, 4-toluidine salt (BCIP) solutions
(Roche Diagnostics, Rotkreuz, Switzerland). In each
experiment, we counted the number of positive cells in the
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lining of synovial tissues, and the levels of mRNA expres-
sion were calculated as a percentage of positive cells.
Results
Identification of subtracted cDNA
We obtained 44 clones that were upregulated in LD cells
and 44 clones that were upregulated in HD cells (Figs 1
and 2). Forty-six of the 88 clones were identical to
sequences that have previously been identified and char-
acterized. Twenty-nine clones were identical to cDNAs
that have been identified, but with unknown functions so
far, and 13 gene fragments did not show any significant
homology to sequences in the GenBank (NCBI). In LD-
specific clones, there were several extracellular matrix
(ECM) proteins such as EFEMP1, fibrillin, versican, laminin
and fibronectin. There were also some proliferation-related
molecules such as AZI, Fbx3 and nucleosome assembly
protein 1-like 1 (NAP1L1), or cell-activation-associated
molecules such as S100A4 and NFAT5 (Fig. 1). On the
other hand, in HD-specific clones, there were several mol-
ecules that induce protein synthesis, such as ribosomal
proteins. We also found the expression of some differenti-
ation markers such as 13kdap and CD26 and genes
associated with inhibition of cell growth, such as EPLIN
and RNASE4 (Fig. 2). We confirmed the efficiency of sub-
traction by PCR according to the manufacturer’s instruc-
tions (data not shown).
Confirmation of differential expression of distinct genes
The LD-specific genes such as EFEMP1, unr and Fbx3
(Fig. 3a), and the HD-specific genes such as CD26,
13kdap and RNASE4 (Fig. 3b) were upregulated in LD
and HD cells, respectively. These results indicated that
the subtracted cDNA represented the part of genes actu-
ally expressed in a culture condition-dependent manner.
The results of actin-β and GAPDH indicated that we com-
pared equal amounts of template cDNA in these experi-
ments (Fig. 3c).
Expression of distinct genes in situ
We investigated the expression and distribution of distinct
genes, namely S100A4, NFAT5, Fbx3 and unr, all of
which were upregulated in LD cells, by in situ hybridiza-
tion. S100A4 mRNA was expressed both in the lining and
sublining layer of RA synovium (Fig. 4). The same expres-
sion pattern was shown by unr (see Supplementary mater-
ial). We also detected the expression of NFAT5 mRNA in
RA synovium (Fig. 5). Interestingly, NFAT5, as well as
Fbx3, mRNA was also expressed at sites of bone destruc-
tion (Fig. 6 and see Supplementary material). These
results indicate that NFAT5 and Fbx3 could be correlated
not only with the proliferation but also with the activation
and invasion of RA-SF in vivo. It is noteworthy that these
four genes (i.e. S100A4, unr, NFAT5, Fbx3) were pre-
dominantly expressed in synovial tissues from patients
with RA rather than from normal individuals (see Supple-
mentary material), suggesting that these genes could con-
tribute to the pathogenesis of RA.
Discussion
We analyzed the expression profile of proliferating RA-SF
in comparison with that of nonproliferating RA-SF, and we
observed that distinct sets of genes, including several
novel genes that have not been associated with RA, were
expressed differentially in proliferating RA-SF by using a
PCR-based suppression subtractive hybridization technique.
Available online http://arthritis-research.com/4/5/R8
Figure 1
The list of clones obtained by forward (LD-specific) subtraction. We
divided these clones into three categories. (a) This category consists
of already identified and characterized genes. (b) This category
includes the genes with sequences previously identified, but with
unknown functions so far. The name of each clone is shown. (c) List of
novel gene fragments that did not show any significant homology to
sequences in GenBank (NCBI). We mention just the name of clones in
our experiments.
Antizyme inhibitor
F-box only protein 3 (Fbx3)
Nucleosome assembly protein 1-like 1
Lysosome-associated membrane protein 2
EGF-containing fibulin-like extracellular
 matrix protein 1 (EFEMP1)
Fibrillin 1
Versican
Laminin  γ1
Fibronectin
Aldose reductase
S100 calcium-binding protein A4 (S100A4)
Semaphorin E
Pepstatin-insensitive lysosomal peptidase
Dihydrodiol dehydrogenase 2
Lactate dehydrogenase B
Nuclear factor of activated T cells 5 (NFAT5)
Upstream of N-ras (unr)
FBR35
KIAA0143
335E3
KAT05223
RP1-187N21
KIAA0093
RP1-242G1
LOC51065
A9A2BRB5
HP10085
KIAA1562
KIAA0660
RP1-86D1
PLACE1001168
LDS6
LDS7
LDS8
LDS12
LDS14
LDS17
LDS34
LDS43
(a) (b)
(c)
Figure 2
The list of clones obtained by reverse (HD-specific) subtraction. We
divided these clones into the same three categories as described in
Figure 1.
(a) (b)
(c)
 FLB8331
HSPC241
HEP01486
TSAP19
KAIA2887
DKFZp586H0523
KAT08245
RP11-48B24
RP11-467H10
KIAA1128
RP11-467P9
RP4-541C22
KAT05659
HDS8
HDS12
HDS34
HDS37
HDS41
Glutamine synthetase
Ribosomal protein S4 X-linked
Ribosomal protein L32
Ribosomal protein L23
13 kDa differentiation associated protein
Calmodulin I
Tumor-associated antigen L6
Small nuclear ribonucleoprotein
 polypeptide B“
Tomoregulin
CDC10
CD26
Glucocorticoid receptor
Dynein
Ubiquitin conjugating enzyme E2A
Staufen
Epithelial protein lost in neoplasm (EPLIN)
RNASE 4
It is useful for development of novel therapeutic
approaches to identify the expression profiles in disease-
associated cells or conditions [12,13], and there are some
reports that identified genes specifically expressed in
rheumatoid synovial cells by using a cDNA subtraction or
a differential display method [14–17]. Since we used RA-
SF from the same patient, at the same passage and cul-
tured with the same medium, we could exclude genetic
polymorphism between individuals, and could identify spe-
cific genes dependent on proliferation or cell density.
In LD-specific subtracted cDNA, we isolated several inter-
esting molecules that play an important role in cell prolifera-
tion. For example, we found upregulation of several ECM
proteins. ECM proteins not only serve just as a mechanical
structure, but also play an important role in many biological
functions, such as cell migration, proliferation and differen-
tiation [18]. Indeed, it was reported that versican stimulates
cell proliferation [19,20], and EFEMP1 stimulates DNA
synthesis when microinjected into fibroblasts [21].
Fibronectin fragments play an important role in proliferation,
Arthritis Research    Vol 4 No 5 Masuda et al.
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Figure 3
The differential expression of distinct genes. It was confirmed by semiquantitative RT-PCR. (a) LD-specific genes such as EFEMP1, unr and Fbx3,
and (b) HD-specific genes such as CD26, 13kdap and RNASE4 were upregulated in LD and HD cells, respectively. (c) The results of actin-β and
GAPDH indicated that we compared equal amounts of template cDNA in these experiments. We analyzed three independent RA-SF and show the
representative results.
1   1:3  1:9
LD
(a)
(c)
(b)
Actin-β
G3PDH
unr
RNASE4
13kdap
CD26
Fbx3
EFEMP1
1   1:3  1:9
HD
1   1:3  1:9
LD
1   1:3  1:9
HD
1   1:3  1:9
LD
1   1:3  1:9
HD
Figure 4
The expression of S100A4 mRNA in sections from patients with RA by
in situ hybridization. This figure shows antisense (a,b) and sense (c)
staining, respectively. We also performed HE staining (d) in serial
sections. The original magnifications are 200× (a,c,d) and 400× (b),
respectively.
Figure 5
The expression of NFAT5 mRNA in sections from patients with RA by
in situ hybridization. This figure shows antisense (a,b) and sense (c)
staining, respectively. We also performed HE staining (d) in serial
sections. The original magnifications are 100× (a,c,d) and 200× (b),
respectively.
adhesion and matrix metalloproteinase expression of RA-
SF [22]. The expression of ECM proteins in proliferating
RA-SF, therefore, could stimulate their proliferation and dif-
ferentiation in an autocrine and/or paracrine manner.
The expression of proliferation-related molecules such as
AZI, Fbx3 and NAP1L1 was also observed in LD cells.
AZI induces polyamine synthesis, which is essential for
cell growth [23,24], and it was reported that AZI is differ-
entially expressed in tumor tissues rather than normal
tissues [25]. Although the function of Fbx3 has not been
identified so far, F-box proteins are important for control-
ling the cell cycle [26]. Simon et al. [27] demonstrated
that NAP1L1 is highly expressed in proliferating cells. On
the other hand, unr was also highly expressed in LD cells,
and it was reported that unr interacts with apoptotic pro-
tease-activating factor-1 (Apaf-1) and could modulate a
certain apoptotic pathway [28]. We can hypothesize,
therefore, that these molecules are not only essential for
cell survival and proliferation in general, but could also
play an important role in the proliferation of RA-SF in vitro
and in vivo.
In HD-specific subtracted cDNA, we also obtained several
interesting molecules. Indeed, we found that CD26,
EPLIN and RNASE4 were specifically expressed in non-
proliferating RA-SF. CD26 was originally identified as an
adenosine deaminase complexing protein and T-cell acti-
vation molecule, and it was reported that activated T cells
as well as fibroblasts in rheumatoid synovium expressed
this molecule [29]. Recently, it was shown that the malig-
nant phenotype of melanoma cells is suppressed by the
introduction of the exogenous CD26 gene [30]. EPLIN is
downregulated or lost in cancer cell lines and inhibits cell
proliferation when overexpressed [31,32]. On the other
hand, RNASE 4 mediates the antiviral and antiproliferative
roles of interferons and is induced during growth inhibition
in murine cell lines [33]. Recently, Taniguchi et al. [34]
showed that cyclin-dependent kinase inhibitor p16INK4a is
induced in RA-SF by several growth-inhibited conditions,
including irradiation, serum depletion and high cellular
density. Surprisingly, they showed also that the gene
transfer of p16 inhibits proliferation of synovial fibroblasts
in vitro and suppresses rat adjuvant arthritis in vivo. In this
context, EPLIN and RNASE4 genes might also be promis-
ing candidates for gene transfer as a novel approach to
treating RA.
Conclusion
We demonstrated that proliferating RA-SF express a dis-
tinct set of genes clearly different from that of nonproliferat-
ing RA-SF. Moreover, a number of molecules correlated
with cell proliferation and activation, including several novel
genes, were isolated from RA-SF by using suppression
subtractive hybridization. Cooperating with anti-apoptotic
molecules such as sentrin-1 and FLIP, these molecules
could be involved in synovial cell proliferation and activation
and could contribute to matrix destruction at sites of inva-
sion in RA. Last but not least, a consideration of cell
density should be mandatory in any investigation examining
cell proliferation or apoptosis in cell cultures.
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Supplementary Figure 1
The strategy of our experiments. SF from one patient with RA
(passage 6) were cultured in 75 cm2 flasks until reaching confluence.
Then, these cells were collected and seeded in 12-well culture plates
(1.0 × 105 cells/well). At 1, 2, 4, 7, 10 and 14 days after seeding, the
number of cells was counted by the trypan blue exclusion method. At
4 days, the cells at low density (LD) proliferated exponentially, and at
14 days, the cells at high density (HD) almost ceased to proliferate as
a result of contact inhibition. The inserts show the HE staining of SF on
chamber slides at 4 and 14 days after seeding, respectively.
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Supplementary Figure 2
The expression of unr mRNA in sections from patients with RA as
shown by in situ hybridization. This figure shows antisense (a,b) and
sense (c) staining, respectively. We also performed HE staining (d) in
serial sections. The original magnifications are 200× (a,c,d) and 400×
(b), respectively.
Supplementary Figure 3
The expression of Fbx3 mRNA in sections from patients with RA as
shown by in situ hybridization. This figure shows antisense (a,b) and
sense (c) staining, respectively. We also performed HE staining (d) in
serial sections. The original magnifications are 100× (a,c,d) and 400×
(b), respectively.
Supplementary Figure 4
The expression of Fbx3 mRNA in sections from patients with RA by in
situ hybridization. This figure shows antisense (a,b) and sense (c)
staining, respectively. The positive signal was observed not only in
fibroblast-like cells (arrowheads) but also in osteoclast-like cells
(arrow). We also performed HE staining (d) in serial sections. The
original magnifications are 200× (a,c,d) and 400× (b), respectively.
Supplementary Figure 5
Summary of the expression of LD-specific genes in synovial tissues
from patients with RA () and from normal individuals (). In each
experiment, we counted the number of positive cells in the lining of
synovial tissues, and the levels of the mRNA expression were
calculated as a percentage of positive cells. Then, we divided these
data into three groups; namely, below 10% (Low), from 10 to 50%
(Moderate) and more than 50% (High).
Low Moderate High
S100A4   

unr   
 
NFAT5   
Fbx3   
 
